HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2.

Abstract
Vascular endothelial growth factor (VEGF) and its receptors (VEGFR) have been implicated in promoting solid tumor growth and metastasis via stimulating tumor-associated angiogenesis. Here we show that certain "liquid" tumors such as acute myeloid leukemia not only produce VEGF but also express functional VEGFR, resulting in an autocrine loop for tumor growth and propagation. In addition, the leukemia-derived VEGF can also stimulate the production of growth factors, including interleukin 6 (IL6) and granulocyte-macrophage colony stimulating factor (GM-CSF), by human endothelial cells, which in turn further promotes the growth of leukemia cells (the paracrine loop). A fully human anti-VEGFR2 (or kinase insert domain-containing receptor, KDR) antibody, IMC-2C6, strongly blocks KDR/VEGF interaction and neutralizes VEGF-stimulated activation of KDR in endothelial cells. In a system where leukemia cells are co-cultured with endothelial cells, IMC-2C6 inhibits both the production of IL6 and GM-CSF by endothelial cells and the growth of leukemia cells. Finally, IMC-2C6 effectively blocks VEGF-induced migration of KDR+ human leukemia cells, and when administered in vivo, significantly prolonged survival of mice inoculated with KDR+ human leukemia cells. Taken together, our data suggest that anti-KDR antibodies may have broad applications in the treatment of both solid tumors and certain types of leukemia.
AuthorsHaifan Zhang, Yiwen Li, Hongli Li, Rajiv Bassi, Xenia Jimenez, Larry Witte, Peter Bohlen, Daniel Hicklin, Zhenping Zhu
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 45 Issue 9 Pg. 1887-97 (Sep 2004) ISSN: 1042-8194 [Print] United States
PMID15223651 (Publication Type: Journal Article)
CopyrightCopyright 2004 Taylor and Francis Ltd
Chemical References
  • Antibodies
  • Interleukin-6
  • Vascular Endothelial Growth Factor A
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Animals
  • Antibodies (immunology, pharmacology, therapeutic use)
  • Autocrine Communication (drug effects)
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Coculture Techniques
  • Gene Expression Regulation, Neoplastic
  • Granulocyte-Macrophage Colony-Stimulating Factor (biosynthesis, metabolism)
  • Humans
  • Interleukin-6 (biosynthesis, metabolism)
  • Leukemia (drug therapy, metabolism, pathology)
  • Male
  • Mice
  • Paracrine Communication (drug effects)
  • Umbilical Cord (immunology, metabolism)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors, biosynthesis, metabolism, pharmacology)
  • Vascular Endothelial Growth Factor Receptor-2 (antagonists & inhibitors, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: